Histopathologic and morphological analysis of heart post-MI showed reduced infarct size areas in animals treated with REMD2.59, whereas glucagon-injected animals showed a trend toward larger infarct size areas.
← all excerpts
Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
1
—
—